monocrotaline has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devendra, BN; Didla, S; Kiranmayi, P; Kusuma, SS; Tanneeru, K | 1 |
| Allen, JR; Hsu, IC; Robertson, KA; Shumaker, RC | 1 |
2 other study(ies) available for monocrotaline and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Antineoplastic activity of monocrotaline against hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; BALB 3T3 Cells; Carcinoma, Hepatocellular; Cell Proliferation; Computer Simulation; Hep G2 Cells; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Membrane Glycoproteins; Mice; Molecular Docking Simulation; Monocrotaline; Receptors, Immunologic; Triggering Receptor Expressed on Myeloid Cells-1; Tumor Suppressor Protein p53 | 2014 |
Neoplastic transformation in tissues of rats exposed to monocrotaline or dehydroretronecine.
Topics: Animals; Carcinogens; Carcinoma, Hepatocellular; Injections, Subcutaneous; Liver Neoplasms; Male; Monocrotaline; Neoplasm Metastasis; Neoplasms, Experimental; Pyrrolidines; Pyrrolizidine Alkaloids; Rats; Rhabdomyosarcoma | 1976 |